IP Library › Assignment 020453/0163
Patent Assignment
Reel/Frame 020453/0163

Assignment of Assignor's Interest

Recorded: 2008-02-01 Pages: 4
Assignors
SPENCER, DAVID GELVIN, JR.
Executed: 2008-01-16
HUMPHRIES, JOHN ELLIOTT
Executed: 2008-01-16
Assignee
BIOLEX THERAPEUTICS, INC.
158 CREDLE STREET, PITTSBORO, NORTH CAROLINA, 27312
Covered Properties (4)
Controlled/Sustained Release Interferon Drug Products and Treatment of Hcv Infection Using Same
Application: 60/951,879 →
Controlled/Sustained Released Interferon Drug Products and Treatment of Hcv Infection Using Same
Application: 60/952,140 →
Controlled/Sustained Release Interferon Drug Products and Treatment of Hcv Infection Using Same
Application: 60/978,330 →
Controlled/Sustained Release Interferon Drug Products and Treatment of HCV Infection Using Same
Application: 60/985,526 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 23, 2008
From: DE LEEDE, LEONARDUS GERARDUS JOZEF; VERRIJK, RUDOLF
To: OCTOPLUS N.V.
Reel/Frame 020844/0708 →
Termination of Security Interest Oct 14, 2008
From: S.R. ONE, LIMITED; LSP III OMNI INVESTMENT COOPERATIEF U.A.
To: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
Reel/Frame 021691/0034 →
Termination of Security Interest Oct 14, 2008
From: BIOLEX THERAPEUTICS, INC.
To: OCTOPLUS SCIENCES B.V.; CHIENNA B.V.; OCTOPLUS DEVELOPMENT B.V.; OCTOPLUS TECHNOLOGIES B.V.
Reel/Frame 021701/0168 →
Assignment of Assignor's Interest Dec 5, 2008
From: OCTOPLUS N.V.
To: OCTOPLUS SCIENCES BV
Reel/Frame 021930/0188 →